                         SEQUENCE LISTING

<110>  THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
 
<120>  METHODS AND COMPOUNDS FOR NEOANTIGEN VACCINES

<130>  91482.255WO-PCT

<150>  US 63/166,697
<151>  2021-03-26

<160>  54    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  1

Lys Ala Glu Ile Leu Ser Ser Leu Gly Ala Leu Tyr Tyr Asn Thr 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  2

Pro His Gly Tyr Glu Ile Lys Phe Ile Phe Gly Ile Pro Leu Asp 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  3

Ile Arg Glu Asn Phe Leu Phe Leu Asp Val Phe Phe Glu Ala Leu 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  4

Gln His Asp Lys Glu Gln Lys Met Ile Gly Ser Val Ser Gln Ser 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  5

Gln Glu Asn Thr Cys Asn Ile Thr Ile Glu Gly Leu Asp Ala Glu 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  6

Val Glu Asp Pro Val Tyr Gln Val Ile Ser Glu Thr Ser Arg Asp 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  7

Leu Gly Phe Phe Lys Gln Asn Glu His Gln Asn Leu Leu Phe Val 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  8

Thr Lys Phe Ile Leu Val Glu Phe Pro Gly Ser Leu Ser Met Arg 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  9

Ile Leu Leu Glu Asn Thr Asp Leu Ser Ala Leu Trp Tyr Leu Tyr 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  10

Ser Glu Lys Leu Ser His Leu Lys Ile Thr Gly Asp Ser Phe Leu 
1               5                   10                  15  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  11

Lys Gln Glu Phe Val Lys Pro Lys Ile Val Ser Arg Glu Gly Gly 
1               5                   10                  15  


<210>  12
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  12

Asp Cys Phe Ser Thr Asn Lys Leu Leu Thr Tyr Glu Ala Leu Gly 
1               5                   10                  15  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  13

Lys Ala Ile Glu Lys Glu Met Lys Val Thr Ala Leu Pro Pro Lys 
1               5                   10                  15  


<210>  14
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  14

Asp Lys Glu Phe Val Lys Phe Asn Arg Met His Ala Val Asn Gly 
1               5                   10                  15  


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  15

Ala Arg Ala Leu Ile Leu Leu Pro Thr Arg Glu Leu Ala Leu Gln 
1               5                   10                  15  


<210>  16
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  16

Trp Gln Pro Gln Ser His Ser Arg Gln Gly His Gly Thr Ser Pro 
1               5                   10                  15  


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  17

Ser Ile His Leu Leu Thr Ser Arg Ala Thr Asn Ser Gln Leu Phe 
1               5                   10                  15  


<210>  18
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  18

Gln Val Ile Ala Leu His Cys Ser Gln Ala Gln Ser Ser Val Ser 
1               5                   10                  15  


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  19

Leu Arg Cys Met Gly Asn Asn Gly Ile Cys Arg Ala Ser Cys Lys 
1               5                   10                  15  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  20

Trp Ile Thr Pro Leu Asp His Leu Val Ala Phe Pro Thr Arg Val 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  21

Ala Ile Lys Thr Leu Lys Ser Gly His Met Asp Arg Gln Arg Arg 
1               5                   10                  15  


<210>  22
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  22

Ala Leu Phe Asp Gly Asp Ser His Leu Ser Thr Glu Asn Pro Ala 
1               5                   10                  15  


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  23

Pro Ser Pro Thr Val Leu Arg Ala His Ala Glu Met Ala Leu Asp 
1               5                   10                  15  


<210>  24
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  24

Asp Met Leu Ser Gln Thr Asn Cys Phe Val Ser Leu Trp Leu Pro 
1               5                   10                  15  


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  25

Pro Val Ser Lys Met Arg Met Ala Thr Pro Leu Leu Met Gln Ala 
1               5                   10                  15  


<210>  26
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  26

Ala Ala Met Ala Ala Ala Ala Ala Ala Ala Met Ala Ala 
1               5                   10              


<210>  27
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  27

Ala Ala Met Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala 
1               5                   10              


<210>  28
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  28

Ala Ala Phe Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala 
1               5                   10              


<210>  29
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  29

Ala Ser Met Ser Ala Ala Ser Ala Ala Ser Met Ala Ala 
1               5                   10              


<210>  30
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa can be any naturally occurring amino acid

<400>  30

Ala Ala Xaa Ala Ala Ala Ala Ala Ala Ala Xaa Ala Ala 
1               5                   10              


